Neuroglee Therapeutics
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Openspace Ventures led the Series A round.
Join the community
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare